Works matching IS 10781552 AND DT 2020 AND VI 26 AND IP 5
Results: 41
Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1200, doi. 10.1177/1078155220918006
- By:
- Publication type:
- Article
Polypharmacy and comorbidities among ambulatory cancer patients: A cross-sectional retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1052, doi. 10.1177/1078155219880255
- By:
- Publication type:
- Article
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1225, doi. 10.1177/1078155220927450
- By:
- Publication type:
- Article
Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1266, doi. 10.1177/1078155219893428
- By:
- Publication type:
- Article
Optimizing patient selection for treatment-free remission.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1220, doi. 10.1177/1078155220925167
- By:
- Publication type:
- Article
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1289, doi. 10.1177/1078155220924084
- By:
- Publication type:
- Article
Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1216, doi. 10.1177/1078155220918019
- By:
- Publication type:
- Article
Antiemetic prophylaxis for induction chemotherapy in patients with acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1213, doi. 10.1177/1078155220918017
- By:
- Publication type:
- Article
The role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1190, doi. 10.1177/1078155220915956
- By:
- Publication type:
- Article
Potential medication interactions with paroxetine use for cough in cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1172, doi. 10.1177/1078155220915763
- By:
- Publication type:
- Article
Healthcare professionals' attitudes of implementing a chemotherapy electronic prescribing system: A mixed methods study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1164, doi. 10.1177/1078155219892304
- By:
- Publication type:
- Article
A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1254, doi. 10.1177/1078155219890653
- By:
- Publication type:
- Article
Author's response to letter: Paroxetine for the treatment of intractable and persistent cough in patients diagnosed with cancer.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
The limitations of today's clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1180, doi. 10.1177/1078155220907965
- By:
- Publication type:
- Article
5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1285, doi. 10.1177/1078155220901769
- By:
- Publication type:
- Article
Staff sensitisation to therapeutic monoclonal antibodies resulting from workplace exposure: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1282, doi. 10.1177/1078155220901750
- By:
- Publication type:
- Article
Potential cross-reactivity of polysorbate 80 and cremophor: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1279, doi. 10.1177/1078155219896848
- By:
- Publication type:
- Article
A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1274, doi. 10.1177/1078155219895072
- By:
- Publication type:
- Article
A case of mitoxantrone extravasation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1270, doi. 10.1177/1078155219893736
- By:
- Publication type:
- Article
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1147, doi. 10.1177/1078155219890032
- By:
- Publication type:
- Article
Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1156, doi. 10.1177/1078155219892066
- By:
- Publication type:
- Article
Toxic epidermal necrolysis associated with pembrolizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1259, doi. 10.1177/1078155219890659
- By:
- Publication type:
- Article
Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1248, doi. 10.1177/1078155219890023
- By:
- Publication type:
- Article
Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1141, doi. 10.1177/1078155219889116
- By:
- Publication type:
- Article
Pomalidomide desensitization for hypersensitivity: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1244, doi. 10.1177/1078155219889676
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1128, doi. 10.1177/1078155219888564
- By:
- Publication type:
- Article
Assessment of unintended volume loss of six closed system transfer devices.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1134, doi. 10.1177/1078155219888682
- By:
- Publication type:
- Article
Pembrolizumab-induced thrombotic thrombocytopenic purpura.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1237, doi. 10.1177/1078155219887212
- By:
- Publication type:
- Article
Acceleration of interstitial lung disease induced by raltitrexed.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1241, doi. 10.1177/1078155219887213
- By:
- Publication type:
- Article
Successful treatment of genital warts with cidofovir cream in a pediatric patient with Fanconi anemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1234, doi. 10.1177/1078155219886924
- By:
- Publication type:
- Article
Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1230, doi. 10.1177/1078155219884113
- By:
- Publication type:
- Article
Documentation of medical marijuana use in cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1117, doi. 10.1177/1078155219883912
- By:
- Publication type:
- Article
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1110, doi. 10.1177/1078155219883004
- By:
- Publication type:
- Article
Surveillance of adverse drug reactions and drug–drug interactions with pediatric oncology patients in a south Indian tertiary care hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1103, doi. 10.1177/1078155219882081
- By:
- Publication type:
- Article
Frequency of appropriate lab monitoring of oral chemotherapy in an outpatient setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1097, doi. 10.1177/1078155219882077
- By:
- Publication type:
- Article
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1086, doi. 10.1177/1078155219882076
- By:
- Publication type:
- Article
Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1080, doi. 10.1177/1078155219881680
- By:
- Publication type:
- Article
Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1070, doi. 10.1177/1078155219881489
- By:
- Publication type:
- Article
A simple method to identify undiagnosed drug-induced liver injury (DILI) and its application in oncology pharmacy practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1060, doi. 10.1177/1078155219880604
- By:
- Publication type:
- Article
Detailed assessment and risk factor analysis of corticosteroid-induced psychiatric disorders in pediatric, adolescent, and young adult patients undergoing induction or consolidation therapy for hematologic malignancy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1041, doi. 10.1177/1078155219879992
- By:
- Publication type:
- Article